Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Marine drugs
2025
|
| Subjects: | |
| Online Access: | https://pubmed.ncbi.nlm.nih.gov/39997193/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1868266239812435968 |
|---|---|
| author | Martínez, Henar Santos, Mercedes Pedraza, Lucía Testera, Ana M |
| author_facet | Martínez, Henar Santos, Mercedes Pedraza, Lucía Testera, Ana M Martínez, Henar Santos, Mercedes Pedraza, Lucía Testera, Ana M |
| collection | PubMed - marine biology |
| contents | Advanced Technologies for Large Scale Supply of Marine Drugs. Martínez, Henar Santos, Mercedes Pedraza, Lucía Testera, Ana M Aquatic Organisms Biological Products Animals Biotechnology Humans Microalgae Marine organisms represent a source of unique chemical entities with valuable biomedical potentialities, broad diversity, and complexity. It is essential to ensure a reliable and sustainable supply of marine natural products (MNPs) for their translation into commercial drugs and other valuable products. From a structural point of view and with few exceptions, MNPs of pharmaceutical importance derive from the so-called secondary metabolism of marine organisms. When production strategies rely on marine macroorganisms, harvesting or culturing coupled with extraction procedures frequently remain the only alternative to producing these compounds on an industrial scale. Their supply can often be implemented with laboratory scale cultures for bacterial, fungal, or microalgal sources. However, a diverse approach, combining traditional methods with modern synthetic biology and biosynthesis strategies, must be considered for invertebrate MNPs, as they are usually naturally accumulated in only very small quantities. This review offers a comprehensive examination of various production strategies for MNPs, addressing the challenges related to supply, synthesis, and scalability. It also underscores recent biotechnological advancements that are likely to transform the current industrial-scale manufacturing methods for pharmaceuticals derived from marine sources. |
| format | Artículo científico |
| id | pubmed_39997193 |
| institution | PubMed |
| language | en |
| publishDate | 2025 |
| publisher | Marine drugs |
| record_format | pubmed |
| spellingShingle | Advanced Technologies for Large Scale Supply of Marine Drugs. Martínez, Henar Santos, Mercedes Pedraza, Lucía Testera, Ana M Aquatic Organisms Biological Products Animals Biotechnology Humans Microalgae Advanced Technologies for Large Scale Supply of Marine Drugs. Martínez, Henar Santos, Mercedes Pedraza, Lucía Testera, Ana M Aquatic Organisms Biological Products Animals Biotechnology Humans Microalgae Marine organisms represent a source of unique chemical entities with valuable biomedical potentialities, broad diversity, and complexity. It is essential to ensure a reliable and sustainable supply of marine natural products (MNPs) for their translation into commercial drugs and other valuable products. From a structural point of view and with few exceptions, MNPs of pharmaceutical importance derive from the so-called secondary metabolism of marine organisms. When production strategies rely on marine macroorganisms, harvesting or culturing coupled with extraction procedures frequently remain the only alternative to producing these compounds on an industrial scale. Their supply can often be implemented with laboratory scale cultures for bacterial, fungal, or microalgal sources. However, a diverse approach, combining traditional methods with modern synthetic biology and biosynthesis strategies, must be considered for invertebrate MNPs, as they are usually naturally accumulated in only very small quantities. This review offers a comprehensive examination of various production strategies for MNPs, addressing the challenges related to supply, synthesis, and scalability. It also underscores recent biotechnological advancements that are likely to transform the current industrial-scale manufacturing methods for pharmaceuticals derived from marine sources. |
| title | Advanced Technologies for Large Scale Supply of Marine Drugs. |
| topic | Aquatic Organisms Biological Products Animals Biotechnology Humans Microalgae |
| url | https://pubmed.ncbi.nlm.nih.gov/39997193/ |